Net profit of Zim Laboratories rose 291.30% to Rs 0.90 crore in the quarter ended June 2024 as against Rs 0.23 crore during the previous quarter ended June 2023. Sales rose 21.32% to Rs 81.82 crore in the quarter ended June 2024 as against Rs 67.44 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales81.8267.44 21 OPM %9.837.16 - PBDT6.184.21 47 PBT1.230.19 547 NP0.900.23 291 Powered by Capital Market - Live News

Zim Laboratories will hold a meeting of the Board of Directors of the Company on 3 August 2024.Powered by Capital Market - Live News

Zim Laboratories announced that the Annual General Meeting (AGM) of the company will be held on 27 June 2024.Powered by Capital Market - Live News

Net profit of Zim Laboratories rose 11.74% to Rs 8.09 crore in the quarter ended March 2024 as against Rs 7.24 crore during the previous quarter ended March 2023. Sales rose 11.81% to Rs 117.86 crore in the quarter ended March 2024 as against Rs 105.41 crore during the previous quarter ended March 2023.For the full year,net profit declined 29.39% to Rs 17.25 crore in the year ended March 2024 as against Rs 24.43 crore during the previous year ended March 2023. Sales declined 7.81% to Rs 367.42 crore in the year ended March 2024 as against Rs 398.53 crore during the previous year ended March 2023. ParticularsQuarter EndedYear Ended�Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var. Sales117.86105.41 12 367.42398.53 -8 OPM %13.2814.66 -11.2513.05 - PBDT14.9014.87 0 39.5952.82 -25 PBT11.009.94 11 23.6435.36 -33 NP8.097.24 12 17.2524.43 -29 Powered by Capital Market - Live News

Zim Laboratories will hold a meeting of the Board of Directors of the Company on 13 May 2024Powered by Capital Market - Live News